Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127646181 | 12764618 | 1 | I | 20160911 | 20160912 | 20160920 | 20160920 | PER | US-TEVA-692792USA | TEVA | 80.84 | YR | F | Y | 80.36000 | KG | 20160921 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127646181 | 12764618 | 1 | PS | NUVIGIL | ARMODAFINIL | 1 | Unknown | U | NKDSA | 21875 | |||||||||
| 127646181 | 12764618 | 2 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 127646181 | 12764618 | 3 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127646181 | 12764618 | 4 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127646181 | 12764618 | 1 | Hypersomnia |
| 127646181 | 12764618 | 2 | Hypothyroidism |
| 127646181 | 12764618 | 3 | Depression |
| 127646181 | 12764618 | 4 | Osteoporosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127646181 | 12764618 | Body height decreased | |
| 127646181 | 12764618 | Insomnia | |
| 127646181 | 12764618 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127646181 | 12764618 | 1 | 20160911 | 0 |